Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LIPEGFILGRASTIM for Colony stimulating factor therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where LIPEGFILGRASTIM was used for Colony stimulating factor therapy.

Most Reported Side Effects for LIPEGFILGRASTIM

Side Effect Reports % Deaths Hosp.
Neutropenia 60 14.1% 2 21
Thrombocytopenia 55 12.9% 1 21
Febrile neutropenia 44 10.4% 2 18
General physical health deterioration 44 10.4% 1 43
Pyrexia 37 8.7% 3 32
Diarrhoea 34 8.0% 1 27
Anaemia 30 7.1% 0 24
Dyspnoea 26 6.1% 0 24
Leukopenia 26 6.1% 1 1
Headache 25 5.9% 0 24
Fatigue 23 5.4% 0 16
Pain 23 5.4% 2 17
Abdominal pain 22 5.2% 0 17
Pneumonia 22 5.2% 1 11
Dizziness 20 4.7% 1 18

Other Indications for LIPEGFILGRASTIM

Product used for unknown indication (124) Prophylaxis (94) Neutropenia (66) Breast cancer (30) Colony stimulating factor prophylaxis (16) B-cell lymphoma (12) Exposure during pregnancy (5)

Other Drugs Used for Colony stimulating factor therapy

PEGFILGRASTIM (692) FILGRASTIM (118) BUSULFAN (32) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (28) CYCLOPHOSPHAMIDE (18) FLUDARABINE (18) LENOGRASTIM (14) ALDESLEUKIN (7) EFLAPEGRASTIM-XNST (7) PEGFILGRASTIM-BMEZ (6)

Related Pages

LIPEGFILGRASTIM Full Profile All Colony stimulating factor therapy Drugs LIPEGFILGRASTIM Demographics LIPEGFILGRASTIM Timeline